Wells Fargo has downgraded Celanese Corp (CE) to Equal-Weight from Overweight as of December 18, 2025. The current share price stands at $42.78. This adjustment indicates a shift towards increased caution regarding the company's outlook, potentially reflecting concerns over competitive pressures, market conditions, or execution risks that may affect performance.
Celanese Corp, based in Irving, Texas, operates within the chemicals industry, focusing on technology and specialty materials. The firm is a global producer of engineered polymers, which are utilised in various applications. Its operations are divided into two segments: Engineered Materials and the Acetyl Chain. The Engineered Materials segment develops high-performance specialty polymers for automotive, medical, industrial, and consumer electronics applications. Meanwhile, the Acetyl Chain segment encompasses the production of acetic acid and related products.
The company's market capitalisation is currently $4.0 billion, with a trailing twelve months (TTM) earnings per share (EPS) of -28.26 and a dividend yield of 32.5%. Upcoming earnings are anticipated on August 10, 2026, with an EPS estimate of $1.72 and revenue expected to reach $2.6 billion.
Analyst consensus as of December 1, 2025, indicates a Buy rating, with recent actions including Citigroup maintaining its Buy rating and UBS holding at Neutral. Analyst ratings serve as professional opinions based on research, but they should be considered alongside various factors such as company fundamentals and market trends.
This update provides insight into the evolving perspectives on Celanese Corp as market conditions change.